Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis
Dongjing Zhang(Beijing Tsinghua Chang Gung Hospital), Jinlin Hou(Southern Medical University), Bingyun Lu(Nanfang Hospital), Xiaolong Qi(Zhongda Hospital Southeast University), Zhihong Liu(Chinese Academy of Sciences), Yuanyuan Liu(Ningbo University), Xueru Yin(Key Laboratory of Guangdong Province)
Cited by 22
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
|Journal of Clinical and Translational Hepatology|2017|277
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
|American Journal of Physiology-Renal Physiology|2014|274